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In recent years, basic research in cancer biology and clinical cancer research have been
moving closer together as the crosstalk between academia and industry has grown and as
technological advances have created methodologies with applications at the bench and in
the clinic. This conceptual and technical convergence has created a need to promote the
communication of important scientific findings between the basic and clinical cancer com-
munities. Cancer Cell was launched 17 months ago by Cell Press with the intention of
accomplishing this goal, and, in a short time, has become a respected and high-quality
journal that is known for publishing cutting-edge papers in the cancer research field. In
addition to exciting original research in such areas as novel molecular mechanisms of
secretory breast cancer, innovative antitumor agents, the role of Ras and Myc in tumor
angiogenesis, and reports on promising therapeutic targets and novel diagnostic tools for
leukemias, Cancer Cell publishes a diversity of review formats, including Focus articles on
different types of tumors and molecular targets, Reviews, Previews, Primers, and
Commentaries. In every case, Cancer Cell aims to present articles that are accessible and
of interest to both basic scientists and clinical oncologists, and to encourage dialog
between the bench and the clinic.
A significant part of Cancer Cell’s success is owed to the vision, dedication, and hard
work of its founding Editor, Mariana Resnicoff. As some of you may already know, Mariana
has moved on from her position at Cancer Cell to pursue other opportunities, and we wish
her the best. Mariana joined Cancer Cell with a broad background in both basic and clinical
cancer research and with experience working in academia and industry. As a result, she
had a strong awareness of the need for a journal to bridge the span of modern cancer biol-
ogy. She was an integral part of the journal, shaping it with her tremendous energy, com-
mitment to the scientific community, and passion for publishing the highest-quality work.
We are sorry to see her go, and thank her for her valuable contributions to Cancer Cell’s
success.
Cancer Cell remains an important member of the Cell Press family. A team of experi-
enced Cell Press editors has assumed responsibility for the journal while the search for a
new Cancer Cell Editor is underway. We are committed to maintaining the vision and high
standards that have become hallmarks of the journal. It is our mission at Cancer Cell to
continue to provide a forum for groundbreaking research in cancer, to bring together the
discoveries of basic, translational, and clinical cancer researchers, and to publish work
with broad significance for the entire cancer research community. We would like to express
our appreciation for your support and encouragement in the past and present, and invite
you to continue to contribute exciting work in the future.
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